Document is current
Any future updates will be listed below
-
Authors
Boyer, Naomi https://orcid.org/0000-0002-8366-6777
Upadhyay, Prateek
Hicks, Megan H.
Zarbock, Alexander
Khanna, Ashish K.
Forni, Lui G.
Creagh-Brown, Benedict C.
- License Information
-
More Information
Article History
Received: 20 June 2025
Accepted: 7 September 2025
First Online: 30 September 2025
Declarations
:
: Not applicable.
: Not applicable.
: AZ has received consulting fees from Astute-Biomerieux, Baxter, Bayer, Novartis, Guard Therapeutics, AM Pharma, Paion, Viatris, Renibus, Alexion, Fresenius, research funding from Astute-Biomerieux, Fresenius, Baxter, and speakers’ fees from Astute-Biomerieux, Fresenius, Baxter. AKK consults for Medtronic, Edwards Lifesciences, Philips Research North America, GE Healthcare, Potrero Medical, Sentinel Medical, Retia Medical, Nihon-Kohden USA, Caretaker Medical, TNO, Bayer Corporation, Fifth Eye Inc., Renibus Thera-peutics, Pharmazz Inc., AOP, Viatris, Innoviva Specialty Therapeutics and Zynex Medical. AKK has ownership interests with BrainX LLC. LGF reports honoraria for lectures from La Jolla and Paion and previous research support from La Jolla. No other relevant COI to this article.
